The Critical Balance – Residual Kidney Function and Incremental Transition to Dialysis
Twice-Weekly Hemodialysis in China: Can It Be A Better Option for Initiation or Maintenance Dialysis Therapy?
Yucheng Yan,
Sylvia Ramirez, Shuchi Anand,
Jiaqi Qian,
Li Zuo,
Corresponding Author
Yucheng Yan
DaVita Hospital Management Consulting (Shanghai) Co.Ltd., Shanghai, China
Address correspondence to: Yucheng Yan, MD, PhD, Baoland Plaza, B-19F, Suite 6, 588 Dalian Road, Yangpu District, Shanghai 200082, China, or email: [email protected].Search for more papers by this authorShuchi Anand
Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA, USA
Search for more papers by this authorJiaqi Qian
Department of Nephrology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Search for more papers by this authorYucheng Yan,
Sylvia Ramirez, Shuchi Anand,
Jiaqi Qian,
Li Zuo,
Corresponding Author
Yucheng Yan
DaVita Hospital Management Consulting (Shanghai) Co.Ltd., Shanghai, China
Address correspondence to: Yucheng Yan, MD, PhD, Baoland Plaza, B-19F, Suite 6, 588 Dalian Road, Yangpu District, Shanghai 200082, China, or email: [email protected].Search for more papers by this authorShuchi Anand
Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA, USA
Search for more papers by this authorJiaqi Qian
Department of Nephrology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Search for more papers by this authorConflict of Interest: The authors have no conflicts of interest to declare. Yucheng Yan is supported by research grants from the National Nature Science Foundation of China (81470918).
Abstract
Cumulative evidence indicates it may be worthwhile revisiting the twice-weekly hemodialysis (HD) regimen as a valid option for individualized or incremental treatments for selected patients with end-stage renal disease. In this article, we will review the current evidences on the potential pros and cons of twice-weekly HD compared to thrice-weekly HD including China's experience in the practice of twice-weekly HD. A prudent patient selection and close dialysis adequacy monitoring might be necessary for this medical treatment choice. More randomized prospective controlled studies for the critical evaluation of twice-weekly dialysis are encouraged.
References
- 1Bieber B, Qian J, Anand S, Yan Y, Chen N, Wang M, et al.: Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and Quality of Life in the China Dialysis Outcomes and Practice Patterns study. Nephrol Dial Transplant 29(9): 1770–1777, 2014
- 2Rhee CM, Unruh M, Chen J, Kovesdy CP, Zager P, Kalantar-Zadeh K: Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial 26(6): 720–727, 2013
- 3Hanson JA, Hulbert-Shearon TE, Ojo AO, Port FK, Wolfe RA, Agodoa LY, et al.: Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol 19(6): 625–633, 1999
- 4Fernandez-Lucas M, Teruel-Briones JL, Gomis-Couto A, Villacorta-Perez J, Quereda-Rodriguez-Navarro C: Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen. Nefrologia 32(6): 767–776, 2012
- 5Lin X, Yan Y, Ni Z, Gu L, Zhu M, Dai H, et al.: Clinical outcome of twice-weekly hemodialysis patients in Shanghai. Blood Purif 33(1–3): 66–72, 2011
- 6Stankuviene A, Ziginskiene E, Kuzminskis V, Bumblyte IA: Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998–2005. Medicina (Kaunas) 46(8): 516–521, 2010
- 7Elamin S, Abu-Aisha H: Reaching target hemoglobin level and having a functioning arteriovenous fistula significantly improve one year survival in twice weekly hemodialysis. Arab J Nephrol Transplant. 5(2): 81–86, 2012
- 8Hwang HS, Hong YA, Yoon HE, Chang YK, Kim SY, Kim YO, et al.: Comparison of Clinical outcome between twice-weekly and thrice-weekly hemodialysis in patients with residual kidney function. Medicine 95(7): e2767, 2016
- 9Wang AY, Lai KN: The importance of residual renal function in dialysis patients. Kidney Int 69(10): 1726–1732, 2006
- 10Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am SocNephrol 15(4): 1061–1070, 2004
- 11Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, et al.: Effect of frequent hemodialysis on residual kidney function. Kidney Int 83(5): 949–958, 2013
- 12Lin YF, Huang JW, Wu MS, Chu TS, Lin SL, Chen YM, et al.: Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology 14(1): 59–64, 2009
- 13Zhang M, Wang M, Li H, Yu P, Yuan L, Hao C, et al.: Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. Am J Nephrol 40(2): 140–150, 2014
- 14Daugirdas JT, Bernardo AA: Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia. Kidney Int 82(2): 147–157, 2012
- 15Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH, et al.: Risk of vascular access complications with frequent hemodialysis. J Am SocNephrol 24(3): 498–505, 2013
- 16Park HS, Kim WJ, Kim YK, Kim HW, Choi BS, Park CW, et al.: Comparison of outcomes with arteriovenous fistula and arteriovenous graft for vascular access in hemodialysis: a prospective cohort study. Am J Nephrol 43(2): 120–128, 2016
- 17Kalantar-Zadeh K, Unruh M, Zager PG, Kovesdy CP, Bargman JM, Chen J, et al.: Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64(2): 181–186, 2014
- 18Kamyar Kalantar-Zadeh, Francesco G. Casino. Let us give twice-weekly hemodialysis a chance: revisiting the taboo. Nephrol Dial Transplant 29(9): 1618–1620, 2014
- 19Depner T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C, et al.: Hemodialys is Study Group: dialysis dose and the effect of gender and body size on outcome in the hemo study. Kidney Int 65(4): 1386–1394, 2004
- 20Port FK, Wolfe RA, Hulbert-Shearon TE, McCullough KP, Ashby VB, Held PJ: High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis 43(6): 1014–1023, 2004
- 21 National Kidney Foundation: KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 66(5): 884–930, 2015
- 22Panaput T, Thinkhamrop B, Domrongkitchaiporn S, Sirivongs D, Praderm L, Anukulanantachai J, et al.: Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study. Blood Purif 38(3–4): 253–262, 2014
- 23Chauhan R, Mendonca S: Adequacy of twice weekly hemodialysis in end stage renal disease patients at a tertiary care dialysis centre. Indian J Nephrol 25(6): 329–333, 2015
- 24Supasyndh O, Satirapoj B, Seenamngoen S, Yongsiri S, Choovichian P, Vanichakarn S: Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6. J Med Assoc Thai 92(5): 624–631, 2009
- 25Caria S, Cupisti A, Sau G, Bolaso P: The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients. BMC Nephrol 15: 172, 2014
- 26Obi Y, Eriguchi R, Ou S, Rhee CM, Kalantar-Zadeh K: What is known and unknown about twice-weekly hemodialysis. Blood Purif 40(4): 298–305, 2015
- 27Zuo L, Wang M, Hou F, Yan Y, Chen N, Qian J, et al.: Anemia management in the China dialysis outcomes and practice patterns study. Blood Purif 42(1): 33–43, 2016
- 28Foley RN, Herzog CA, Collins AJ: United States Renal Data System: blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int 62(5): 1784–1790, 2002
- 29Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am SocNephrol 4(5): 914–920, 2009
- 30Shoji T, Tsubakihara Y, Fujii M, Imai E: Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 66(3): 1212–1220, 2004
- 31Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 79(2): 250–257, 2011
- 32Obi Y, Streja E, Rhee CM, Ravel V, Amin AN, Cupisti A, et al.: Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis 68(2): 256–265, 2016
Citing Literature
